197 related articles for article (PubMed ID: 30127624)
1. An integrated bioinformatical analysis to evaluate the role of KIF4A as a prognostic biomarker for breast cancer.
Xue D; Cheng P; Han M; Liu X; Xue L; Ye C; Wang K; Huang J
Onco Targets Ther; 2018; 11():4755-4768. PubMed ID: 30127624
[TBL] [Abstract][Full Text] [Related]
2. Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer.
Taniwaki M; Takano A; Ishikawa N; Yasui W; Inai K; Nishimura H; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6624-31. PubMed ID: 18006763
[TBL] [Abstract][Full Text] [Related]
3. KIF4A: A potential biomarker for prediction and prognostic of prostate cancer.
Chen J; Li M; Fang S; Zhou X; Liao J; Yang S; Zhu J; He R; Lu J; Jiang F; Xu X; Zhong W
Clin Invest Med; 2020 Sep; 43(3):E49-59. PubMed ID: 32971585
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of KIF4A in colorectal cancer is associated with lymph node metastasis.
Matsumoto Y; Saito M; Saito K; Kanke Y; Watanabe Y; Onozawa H; Hayase S; Sakamoto W; Ishigame T; Momma T; Kumamoto K; Ohki S; Takenoshita S
Oncol Lett; 2018 Feb; 15(2):2188-2194. PubMed ID: 29434924
[TBL] [Abstract][Full Text] [Related]
5. KIF4A is a promising prognostic marker and correlates with immune infiltration in clear cell renal cell carcinoma.
Li C; Chen J; Su Z
Transl Cancer Res; 2020 Nov; 9(11):7165-7173. PubMed ID: 35117320
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of KIF4A in osteosarcoma predicts a poor prognosis and facilitates tumor growth by activation of the MAPK pathway.
Zhu D; Xu X; Zhang M; Wang T
Exp Ther Med; 2021 Nov; 22(5):1339. PubMed ID: 34630693
[TBL] [Abstract][Full Text] [Related]
7. Identification of KIF4A as a pan-cancer diagnostic and prognostic biomarker via bioinformatics analysis and validation in osteosarcoma cell lines.
Pan J; Lei X; Mao X
PeerJ; 2021; 9():e11455. PubMed ID: 34055488
[TBL] [Abstract][Full Text] [Related]
8. KIF4A promotes epithelial-mesenchymal transition by activating the TGF-β/SMAD signaling pathway in glioma cells.
Xu Y; Xue G; Zhou L; Wu G; Hu L; Ma S; Zhang J; Li X
Mol Cell Biochem; 2024 Feb; ():. PubMed ID: 38411896
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential prognostic biomarkers for breast cancer using WGCNA and PPI integrated techniques.
Zheng G; Zhang C; Zhong C
Ann Diagn Pathol; 2021 Feb; 50():151675. PubMed ID: 33291061
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatic and Experimental Analyses Reveal That KIF4A Is a Biomarker of Therapeutic Sensitivity and Predicts Prognosis in Cervical Cancer Patients.
Wu J; Li L; Zhong H; Zhang HH; Li J; Zhang HB; Zhao YQ; Xu B; Song QB
Curr Med Sci; 2022 Dec; 42(6):1273-1284. PubMed ID: 36260268
[TBL] [Abstract][Full Text] [Related]
11. Impact of KIF4A on Cancer Stem Cells and EMT in Lung Cancer and Glioma.
Kahm YJ; Kim IG; Jung U; Lee JH; Kim RK
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067227
[TBL] [Abstract][Full Text] [Related]
12. Kinesin family member 4A: a potential predictor for progression of human oral cancer.
Minakawa Y; Kasamatsu A; Koike H; Higo M; Nakashima D; Kouzu Y; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2013; 8(12):e85951. PubMed ID: 24386490
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of kinesin family member 4A enhanced cell proliferation via activation of Akt signaling and predicted a poor prognosis in hepatocellular carcinoma.
Huang Y; Wang H; Lian Y; Wu X; Zhou L; Wang J; Deng M; Huang Y
Cell Death Dis; 2018 Feb; 9(2):141. PubMed ID: 29396392
[TBL] [Abstract][Full Text] [Related]
14. Upregulate KIF4A Enhances Proliferation, Invasion of Hepatocellular Carcinoma and Indicates poor prognosis Across Human Cancer Types.
Hou G; Dong C; Dong Z; Liu G; Xu H; Chen L; Liu L; Wang H; Zhou W
Sci Rep; 2017 Jun; 7(1):4148. PubMed ID: 28646197
[TBL] [Abstract][Full Text] [Related]
15. Integrative analysis of KIF4A, 9, 18A, and 23 and their clinical significance in low-grade glioma and glioblastoma.
Cho SY; Kim S; Kim G; Singh P; Kim DW
Sci Rep; 2019 Mar; 9(1):4599. PubMed ID: 30872592
[TBL] [Abstract][Full Text] [Related]
16. Increased KIF4A expression is a potential prognostic factor in prostate cancer.
Gao H; Chen X; Cai Q; Shang Z; Niu Y
Oncol Lett; 2018 May; 15(5):7941-7947. PubMed ID: 29725481
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of KPNA2 predicts unfavorable prognosis in ovarian cancer patients, possibly by targeting KIF4A signaling.
Cui X; Wang H; Wu X; Huo K; Jing X
J Ovarian Res; 2021 May; 14(1):71. PubMed ID: 34034774
[TBL] [Abstract][Full Text] [Related]
18. KIF4A enhanced cell proliferation and migration via Hippo signaling and predicted a poor prognosis in esophageal squamous cell carcinoma.
Sun X; Chen P; Chen X; Yang W; Chen X; Zhou W; Huang D; Cheng Y
Thorac Cancer; 2021 Feb; 12(4):512-524. PubMed ID: 33350074
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and Therapeutic Significance of Adhesion-regulating Molecule 1 in Estrogen Receptor-positive Breast Cancer.
Wu W; Zhong J; Chen J; Niu P; Ding Y; Han S; Xu J; Dai L
Clin Breast Cancer; 2020 Apr; 20(2):131-144.e3. PubMed ID: 31669266
[TBL] [Abstract][Full Text] [Related]
20. KIF4A knockdown suppresses ovarian cancer cell proliferation and induces apoptosis by downregulating BUB1 expression.
Jin W; Ye L
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34013367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
